ARCHIVES

Drug Effectiveness Weakens After Three Years, Study Says

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

Hopkins Investigator Dies In Fall From Denver Hotel Window

May 27, 1977

ASA Honors Bernard Fisher With Surgeons’ Highest Award.

April 21, 2000

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

February 13, 1998

Vanderbilt-Ingram Wins NCI SPORE Grant

April 19, 2002

NIH News: Varmus Presents “Modest Proposal for a Simpler NIH”

August 6, 1999